Key facts
- R1 RCM’s last known valuation is $8.9B (Nov 2024).
- It has raised $3.2M.
- Notable investors include Khosla Ventures, TowerBrook Capital Partners, Clayton, Dubilier & Rice.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for R1 RCM
- ·The full record, as it builds
Funding rounds
No funding rounds for R1 RCM are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About R1 RCM
Provider of revenue cycle management services intended to serve hospitals, health systems, and physician groups. The company offers end-to-end revenue cycle services, including personnel, technology, and process workflow, enabling clients to improve operating margins and cash flow while enhancing patient, physician, and staff satisfaction.
- Sector
- Healthcare
- HQ
- Murray, UT, United States
- Founded
- 2003
- Employees
- 34,000
- Website
- r1rcm.com/
- Ownership
- Privately Held (backing)
R1 RCM doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in R1 RCM shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on R1 RCM in its N-PORT filings yet. We sweep new filings monthly.